Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added the disease term Small cell lung carcinoma and the Genetic and Rare Diseases Information Center as a resources entry.
    Difference
    0.1%
    Check dated 2026-03-28T03:24:29.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Study protocol revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:03:59.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    - Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-06T19:02:52.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page; this is a minor version change with no impact on core content — To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:46:13.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1; no changes to page content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:55:26.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    UI and metadata updates are present, including a 'Show glossary' option, capitalization adjustments for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision indicator updated to v3.4.0. These changes do not alter core study content, endpoints, or results display.
    Difference
    0.1%
    Check dated 2026-01-29T07:53:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.